Laboratori Baldacci is committed to studying new biochemical mechanisms underlying the pharmacological and therapeutic activity of its own products, such as Aminaphtone, Metadoxine and Lactobacillus rhamnosus BMX 54.

Partnerships with Centres of Excellence, qualified in Italy and abroad, have enabled these projects to go ahead.

Such commitment also goes hand in hand with the development of new products in therapeutic areas of interest for the Company.